Penile cancer
Section editor | |
---|---|
Eddy J. Chen, MD Massachusetts General Hospital Boston, MA |
9 regimens on this page
10 variants on this page
|
Guidelines
ESMO
- 2013: Van Poppel et al. Penile cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
NCCN
Neoadjuvant chemotherapy
TIP
back to top |
TIP: Taxol (Paclitaxel), Ifosfamide, Platinol (Cisplatin)
Regimen
Study | Evidence |
---|---|
Pagliaro et al. 2010 | Phase II |
Note: cycle was repeated on day 22 if the patient's ANC was at least 1400/uL and platelet count was at least 100 x 109/L.
Chemotherapy
- Paclitaxel (Taxol) 175 mg/m2 IV over 3 hours once on day 1
- Ifosfamide (Ifex) 1200 mg/m2 IV over 2 hours once per day on days 1 to 3
- Cisplatin (Platinol) 25 mg/m2 IV over 2 hours once per day on days 1 to 3
- Administered intravenously in 250 mL of normal saline containing 12.5 g of mannitol
Supportive medications
- Mesna (Mesnex) as follows:
- 400 mg/m2 IV once before each dose of Ifosfamide (Ifex)
- 200 mg/m2 IV given twice, at 4 and 8 hours after each dose of Ifosfamide (Ifex)
- After Cisplatin (Platinol), hydration with 3 liters of a solution of 5% dextrose, sodium chloride, potassium chloride, magnesium sulfate, and mannitol
- One of the following dexamethasone doses:
- Dexamethasone (Decadron) 8 mg IV once 1 hour before Paclitaxel (Taxol)
- Dexamethasone (Decadron) 20 mg PO given twice, at 12 and 6 hours before Paclitaxel (Taxol)
- Diphenhydramine (Benadryl) 50 mg IV once, prior to Paclitaxel (Taxol)
- One of the following H2 blockers:
- Cimetidine (Tagamet) 300 mg IV once, prior to Paclitaxel (Taxol)
- Ranitidine (Zantac) 50 mg IV once, prior to Paclitaxel (Taxol)
- Famotidine (Pepcid) 20 mg IV once, prior to Paclitaxel (Taxol)
- "The use of prophylactic G-CSF was allowed but not required"
21 to 28-day cycle for 4 cycles
Subsequent treatment
References
- Pagliaro LC, Williams DL, Daliani D, Williams MB, Osai W, Kincaid M, Wen S, Thall PF, Pettaway CA. Neoadjuvant paclitaxel, ifosfamide, and cisplatin chemotherapy for metastatic penile cancer: a phase II study. J Clin Oncol. 2010 Aug 20;28(24):3851-7. Epub 2010 Jul 12. link to original article contains verified protocol link to PMC article PubMed
VBM
back to top |
VBM: Vincristine, Bleomycin, Methotrexate
Regimen
Study | Evidence |
---|---|
Pizzocaro et al. 1988 | Pilot, <20 pts |
Note: this is of historic interest given the toxicity of bleomycin-containing regimens.
Preceding treatment
- Surgery, within 2 to 4 weeks
Chemotherapy
- Bleomycin (Blenoxane) 15 mg IM twice per week, 6 hours and 24 hours after vincristine
- Vincristine (Oncovin) 1 mg IV once per week
- Methotrexate (MTX) 30 mg PO once per week, 48 hours after vincristine
12-week course
Subsequent treatment
References
- Pizzocaro G, Piva L. Adjuvant and neoadjuvant vincristine, bleomycin, and methotrexate for inguinal metastases from squamous cell carcinoma of the penis. Acta Oncol. 1988;27(6b):823-4. link to original article contains verified protocol PubMed
- Review: Pagliaro LC, Crook J. Multimodality therapy in penile cancer: when and which treatments? World J Urol. 2009 Apr;27(2):221-5. Epub 2008 Aug 6. link to original article contains verified protocol link to PMC article PubMed
Adjuvant chemotherapy
DCF
back to top |
DCF: Docetaxel, Cisplatin, Fluorouracil
Regimen
Study | Evidence |
---|---|
Necchi et al. 2011 | Case report |
Preceding treatment
Chemotherapy
- Docetaxel (Taxotere) 75 mg/m2 IV once on day 1
- Cisplatin (Platinol) 75 mg/m2 IV once on day 1
- Fluorouracil (5-FU) 750 mg/m2/day IV continuous infusion on days 1 to 4 (total dose per cycle: 3000 mg/m2)
21-day cycle for 3 cycles
References
- Case report: Necchi A, Nicolai N, Colecchia M, Catanzaro M, Torelli T, Piva L, Salvioni R. Proof of activity of anti-epidermal growth factor receptor-targeted therapy for relapsed squamous cell carcinoma of the penis. J Clin Oncol. 2011 Aug 1;29(22):e650-2. Epub 2011 May 31. link to original article contains verified protocol PubMed
TIP
back to top |
TIP: Taxol (Paclitaxel), Ifosfamide, Platinol (Cisplatin)
Regimen
Note: No primary reference available, but some guidelines state that it is reasonable to give adjuvant TIP if it was not given preoperatively and pathology shows high-risk features. (see neoadjuvant TIP for a referenced regimen)
Preceding treatment
Chemotherapy
References
- No primary reference available
Metastatic or unresectable disease
BMP
back to top |
BMP: Bleomycin, Methotrexate, Platinol (Cisplatin)
MPB: Methotrexate, Platinol (Cisplatin), Bleomycin
Variant #1
Study | Evidence |
---|---|
Haas et al. 1999 (SWOG 8520) | Phase II |
This is likely of historic interest due to the toxicity of bleomycin-containing regimens.
Chemotherapy
- Bleomycin (Blenoxane) 10 units/m2 IV bolus once per day on days 1 & 8
- Chemotherapy with bleomycin was discontinued when a total cumulative dose of 200 units/m2 was reached
- Methotrexate (MTX) 25 mg/m2 IV bolus once per day on days 1 & 8
- Cisplatin (Platinol) 75 mg/m2 at a concentration of 1 mg/mL normal saline IV given at a rate of 1 mg/min once on day 1
Supportive medications
- Normal saline IV at 250 mL/hour, starting 1 hour before Cisplatin (Platinol) and continued at least 6 hours after completion of Cisplatin (Platinol)
- Furosemide (Lasix) 40 mg IV once, prior to Cisplatin (Platinol)
21-day cycles, given until disease progression; patients who achieved complete remission discontinued therapy after 6 cycles
Variant #2
Study | Evidence |
---|---|
Corral et al. 1998 | Phase II |
21 of 29 evaluable patients in Corral et al. 1998 had penile cancer. Please see the paper for additional variations in the protocol, including some patients being treated with intraarterial therapy. This is likely of historic interest due to the toxicity of bleomycin-containing regimens.
Chemotherapy
- Bleomycin (Blenoxane) 10 mg/m2 IV once per day on days 2 to 6
- Note: Pagliaro et al. 2009 lists a "dosage of 50 mg/m2 on days 2 to 6," which could be misinterpreted as 50 mg/m2 for each dose, which is in contrast to the 50 mg/m2 for each cycle that Corral et al. 1998 describes.
- Methotrexate (MTX) 200 mg/m2 IV once per day on days 1, 15, 22
- Cisplatin (Platinol) 20 mg/m2 IV over 3 hours once per day on days 2 to 6
- Note: Corral et al. 1998 does not specify which days cisplatin is given on. Pagliaro et al. 2009 specifies that cisplatin is given on days 2 to 6. For Corral et al. 1998, the 5 day course is inferred based on the paper saying that the total dosage--presumably per cycle--was 100 mg/m2.
Supportive medications
- Folinic acid (Leucovorin) 25 mg PO every 6 hours x 12 doses, starting 24 hours after each dose of Methotrexate (MTX)
28-day cycles
References
- Corral DA, Sella A, Pettaway CA, Amato RJ, Jones DM, Ellerhorst J. Combination chemotherapy for metastatic or locally advanced genitourinary squamous cell carcinoma: a phase II study of methotrexate, cisplatin and bleomycin. J Urol. 1998 Nov;160(5):1770-4. link to original article contains verified protocol PubMed
- Haas GP, Blumenstein BA, Gagliano RG, Russell CA, Rivkin SE, Culkin DJ, Wolf M, Crawford ED. Cisplatin, methotrexate and bleomycin for the treatment of carcinoma of the penis: a Southwest Oncology Group study. J Urol. 1999 Jun;161(6):1823-5. link to original article contains verified protocol PubMed content property of HemOnc.org
- Review: Pagliaro LC, Crook J. Multimodality therapy in penile cancer: when and which treatments? World J Urol. 2009 Apr;27(2):221-5. Epub 2008 Aug 6. link to original article contains verified protocol link to PMC article PubMed
Cisplatin & Fluorouracil
back to top |
Regimen
Study | Evidence |
---|---|
Shammas et al. 1992 | Pilot, <20 pts |
Chemotherapy
- Cisplatin (Platinol) 100 mg/m2 IV once on day 1
- Fluorouracil (5-FU) 1000 mg/m2/day IV continuous infusion over 120 hours, started on day 1 (total dose per cycle: 5000 mg/m2)
References
- Shammas FV, Ous S, Fossa SD. Cisplatin and 5-fluorouracil in advanced cancer of the penis. J Urol. 1992 Mar;147(3):630-2. link to SD article contains protocol PubMed
Cisplatin & Irinotecan
back to top |
Regimen
Study | Evidence |
---|---|
Theodore et al. 2008 (EORTC 30992) | Phase II |
Chemotherapy
- Cisplatin (Platinol) 80 mg/m2 IV over 1 to 3 hours once on day 1, given second
- Irinotecan (Camptosar) 60 mg/m2 IV over 30 minutes once per day on days 1, 8, 15, given first
Supportive medications
- Adequate hydration with cisplatin, per guidelines at each investigator's site
- Antiemetic medication per routine local practice.
- "Systematic premedication with atropine as of the first cycle of treatment was at the investigator's discretion but was not recommended."
28-day cycles, with up to 4 cycles before surgery in the neoadjuvant setting for T3 or N1 to N2; up to 8 cycles for patients with T4, N3, or M+ distant metastatic disease
References
- Theodore C, Skoneczna I, Bodrogi I, Leahy M, Kerst JM, Collette L, Ven K, Marréaud S, Oliver RD; EORTC Genito-Urinary Tract Cancer Group. A phase II multicentre study of irinotecan (CPT 11) in combination with cisplatin (CDDP) in metastatic or locally advanced penile carcinoma (EORTC PROTOCOL 30992). Ann Oncol. 2008 Jul;19(7):1304-7. link to original article contains verified protocol PubMed
Paclitaxel monotherapy
back to top |
Regimen
Study | Evidence |
---|---|
Di Lorenzo et al. 2011 | Phase II |
Chemotherapy
- Paclitaxel (Taxol) 175 mg/m2 IV over 3 hours once on day 1
Supportive medications
- G-CSF could be used in later cycles if the patient developed febrile neutropenia during treatment
- Dexamethasone (Decadron) 8 mg PO given three times, at 12 hours before, immediately before, and 12 hours after paclitaxel
21-day cycles
References
- Di Lorenzo G, Federico P, Buonerba C, Longo N, Cartenì G, Autorino R, Perdonà S, Ferro M, Rescigno P, D'Aniello C, Matano E, Altieri V, Palmieri G, Imbimbo C, De Placido S, Mirone V. Paclitaxel in pretreated metastatic penile cancer: final results of a phase 2 study. Eur Urol. 2011 Dec;60(6):1280-4. link to original article contains verified protocol PubMed
Panitumumab monotherapy
back to top |
Regimen
Study | Evidence |
---|---|
Necchi et al. 2011 | Case report |
Chemotherapy
- Panitumumab (Vectibix) 6 mg/kg IV once on day 1
14-day cycles
References
- Case report: Necchi A, Nicolai N, Colecchia M, Catanzaro M, Torelli T, Piva L, Salvioni R. Proof of activity of anti-epidermal growth factor receptor-targeted therapy for relapsed squamous cell carcinoma of the penis. J Clin Oncol. 2011 Aug 1;29(22):e650-2. Epub 2011 May 31. link to original article contains verified protocol PubMed
PCF
back to top |
PCF: Paclitaxel, Cisplatin, Fluorouracil
Regimen
Study | Evidence |
---|---|
Pizzocaro et al. 2009 | Pilot, <20 pts |
Chemotherapy
- Paclitaxel (Taxol) 120 mg/m2 in 500 mL 5% glucose solution IV once on day 1, given first
- Cisplatin (Platinol) 50 mg/m2 IV once per day on days 1 & 2
- Fluorouracil (5-FU) 1000 mg/m2/day in 2 liters half normal 2.5% glucose saline IV continuous infusion on days 2 to 5
Supportive medications
- "Corticosteroids, antihistamines, and an H2 antagonist were administered before starting paclitaxel"
- "Antiemetic drugs and glutathione were administered before Cisplatin (Platinol)"
- 1 liter half normal 2.5% glucose saline with 20 mEq potassium chloride and 10 mEq magnesium sulfate (MgSO4) IV given twice, before and after Cisplatin (Platinol)
21-day cycles; "two patients received more than the standard four courses"
References
- Pizzocaro G, Nicolai N, Milani A. Taxanes in combination with cisplatin and fluorouracil for advanced penile cancer: preliminary results. Eur Urol. 2009 Mar;55(3):546-51. Epub 2008 Jul 14. link to original article contains verified protocol PubMed
TIP
back to top |
TIP: Taxol (Paclitaxel), Ifosfamide, Platinol (Cisplatin)
Regimen
Note: No primary reference available, but some guidelines state that it is reasonable to give TIP as first-line therapy for metastatic penile cancer (see neoadjuvant TIP for a referenced regimen)
Chemotherapy
References
- No primary reference available